Google Prescribes More Partners

Recs

1

Be A Motley Fool Millionaire!

David Gardner's top pick took an epic run of 1,334%! See what he’s recommending that you buy NEXT.

It's only been a few months since Google (NYSE: GOOG) launched its new health-information aggregation service, but it's already racked up quite a few partners in an effort to overtake Microsoft (Nasdaq: MSFT), WebMD (Nasdaq: WBMD), and Revolution Health, which all predated Google's efforts with similar websites to store health-care information.

Making importing your medical data easy is the key to successfully getting people to use the service. Who the heck would want to have to type in every drug they've ever taken, or decipher their doctor's chicken scratch?

Google Health's founding partners -- CVS Caremark (NYSE: CVS), Walgreen (NYSE: WAG), mail-order benefit manager MedcoHealth Solutions (NYSE: MHS), and laboratory-testing company Quest Diagnostics (NYSE: DGX) just to name a few -- were all a good start, but the search giant has apparently gone up the food chain to sign up the mother of all pharmacy clients.

Instead of signing up each individual client, Google Health is partnering with PDX, a provider of client tracking software to almost 3,000 pharmacies. Now, 55 million customers could potentially integrate their pharmaceutical records into Google Health.

Since PDX is just the software maker, Google Health will still have to sign up the pharmacies individually, but the pitch shouldn't be nearly as hard, since PDX has done all the work to create seamless integration between the pharmacies' databases and Google Health.

Until Google Health establishes a way to get most doctors' records into its system, I think it'll probably remain a niche product, but the partnership with PDX definitely shows that Google has the right prescription for success.

More Foolishness Googled up for you:

“Make Big Money With Options” Motley Fool CFO Ollen Douglass recently made over $100,000 buying options on 7 well known stocks. Now we’re committed to turning his small fortune into a massive one! And we want you to join us! Enter your email address to hear more:

Microsoft and Quest Diagnostics are Motley Fool Inside Value selections. Google is a Motley Fool Rule Breakers pick. MedcoHealth Solutions is a Motley Fool Stock Advisor recommendation. Try any of our Foolish newsletters today, free for 30 days

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 716542, ~/Articles/ArticleHandler.aspx, 12/1/2009 2:24:30 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
The Public Health-Care Plan's Problem

Related Tickers

11/30/2009 4:00 PM
MSFT $29.41 Up +0.19 +0.65%
Microsoft Corp CAPS Rating: ***
MHS $63.16 Up +0.67 +1.07%
Medco Health Solut… CAPS Rating: ****
DGX $57.94 Down -0.33 -0.57%
Quest Diagnostics,… CAPS Rating: ****
WBMD $36.30 Down -0.03 -0.08%
WebMD Health Corp. CAPS Rating: **
CVS $31.01 Down -0.19 -0.61%
CVS Caremark Corp CAPS Rating: ****
WAG $38.89 Down -0.12 -0.31%
Walgreen Company CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Poop and scoop: Poop and scoop is a form of illegal stock manipulation, where a scammer tries to drive down the price of stock through publishing and distributing unsolicited misleading advertising materials so that the scammer can buy the stock at a lower price.

Want to learn more or edit this definition?
Click here to read more!